
GBS GBS
Quarterly report 2025-Q4
added 02-12-2026
GBS Long Term Debt Current 2011-2026 | GBS
Annual Long Term Debt Current GBS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.7 K | 275 K | 223 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 275 K | 84.7 K | 194 K |
Long Term Debt Current of other stocks in the Medical devices industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
6.3 M | $ 11.75 | -3.29 % | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
102 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
1.56 M | - | - | $ 3.31 B | ||
|
Delcath Systems
DCTH
|
101 K | $ 8.98 | -1.32 % | $ 322 M | ||
|
Aziyo Biologics
AZYO
|
355 K | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
718 K | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.37 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
1.35 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
3.88 M | $ 18.41 | 0.38 % | $ 121 M | ||
|
Conformis
CFMS
|
1.93 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
526 K | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
3.16 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
Apollo Endosurgery
APEN
|
543 K | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
995 K | $ 1.35 | - | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
428 K | $ 100.97 | 1.78 % | $ 1.28 B | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
LivaNova PLC
LIVN
|
8.79 M | $ 62.4 | -1.33 % | $ 3.4 B | ||
|
LENSAR
LNSR
|
524 K | $ 5.56 | -8.4 % | $ 64 M | ||
|
AxoGen
AXGN
|
2.35 M | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
8.61 M | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
192 M | $ 86.58 | -0.68 % | $ 111 B | ||
|
NanoVibronix
NAOV
|
52 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
72.3 K | $ 24.7 | 0.86 % | $ 209 M | ||
|
Neovasc
NVCN
|
273 K | - | - | $ 111 M | ||
|
InspireMD
NSPR
|
1.07 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Orthofix Medical
OFIX
|
3.15 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
Cytosorbents Corporation
CTSO
|
453 K | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
313 K | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
259 K | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
888 K | - | -13.19 % | $ 166 K | ||
|
Penumbra
PEN
|
13.8 M | $ 334.17 | -0.41 % | $ 13 B | ||
|
AdaptHealth Corp.
AHCO
|
30.7 M | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
495 K | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Insulet Corporation
PODD
|
3 M | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
519 K | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
3.42 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
802 K | $ 3.91 | 4.83 % | $ 146 M | ||
|
Quanterix Corporation
QTRX
|
7.92 M | $ 3.82 | -3.05 % | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
3.05 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
1.74 M | $ 3.53 | -2.35 % | $ 53.7 K |